Difficulty: Medium
Average Score: 74%
Practice
All the following drugs are oral anticoagulants EXCEPT:
Correct answer
D
Rationale
The correct answer is D) Bivalirudin. Bivalirudin is not an oral anticoagulant; it is administered intravenously.
A) Dabigatran and B) Rivaroxaban are both oral anticoagulants belonging to the direct oral anticoagulant (DOAC) class. These medications work by inhibiting specific clotting factors in the blood to prevent clot formation.
C) Warfarin is an oral anticoagulant that works by interfering with the body's use of vitamin K, which is necessary for the production of clotting factors. Warfarin requires regular monitoring of INR levels to ensure its effectiveness and safety.
Educationally, it is crucial for healthcare professionals to understand the different classes of anticoagulants, their mechanisms of action, routes of administration, monitoring requirements, and potential adverse effects. This knowledge is essential for safe and effective medication management in patients requiring anticoagulation therapy. Understanding the distinctions between these medications helps healthcare providers make informed decisions when choosing the most appropriate anticoagulant for individual patients based on factors such as indication, patient characteristics, and monitoring capabilities.
A) Dabigatran and B) Rivaroxaban are both oral anticoagulants belonging to the direct oral anticoagulant (DOAC) class. These medications work by inhibiting specific clotting factors in the blood to prevent clot formation.
C) Warfarin is an oral anticoagulant that works by interfering with the body's use of vitamin K, which is necessary for the production of clotting factors. Warfarin requires regular monitoring of INR levels to ensure its effectiveness and safety.
Educationally, it is crucial for healthcare professionals to understand the different classes of anticoagulants, their mechanisms of action, routes of administration, monitoring requirements, and potential adverse effects. This knowledge is essential for safe and effective medication management in patients requiring anticoagulation therapy. Understanding the distinctions between these medications helps healthcare providers make informed decisions when choosing the most appropriate anticoagulant for individual patients based on factors such as indication, patient characteristics, and monitoring capabilities.